|
KIAA0664P3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.172820E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.073700E-02 |
| Normal-vs-Stage2 |
4.272800E-01 |
| Normal-vs-Stage3 |
9.600000E-02 |
| Normal-vs-Stage4 |
2.586800E-04 |
| Stage1-vs-Stage2 |
5.816800E-01 |
| Stage1-vs-Stage3 |
9.676600E-01 |
| Stage1-vs-Stage4 |
8.644200E-04 |
| Stage2-vs-Stage3 |
6.644800E-01 |
| Stage2-vs-Stage4 |
1.448180E-02 |
| Stage3-vs-Stage4 |
5.679000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.162000E-01 |
| Normal-vs-AfricanAmerican |
5.765800E-02 |
| Normal-vs-Asian |
2.873500E-02 |
| Caucasian-vs-AfricanAmerican |
3.262600E-01 |
| Caucasian-vs-Asian |
1.936990E-01 |
| AfricanAmerican-vs-Asian |
3.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.081970E-01 |
| Normal-vs-Female |
1.921760E-01 |
| Male-vs-Female |
9.123200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.880200E-02 |
| Normal-vs-Extreme_Weight |
1.897640E-03 |
| Normal-vs-Obese |
3.022000E-01 |
| Normal-vs-Extreme_Obese |
5.740600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.413000E-01 |
| Normal_Weight-vs-Obese |
2.696000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.724200E-01 |
| Extreme_Weight-vs-Obese |
4.375800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.858420E-01 |
| Obese-vs-Extreme_Obese |
9.030600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.132100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.929370E-01 |
| Normal-vs-Age(61-80Yrs) |
1.068620E-01 |
| Normal-vs-Age(81-100Yrs) |
3.947600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.339400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.583980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.282200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.185600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.163600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.248400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.606400E-01 |
| Normal-VS-Type2 PRCC |
1.502920E-03 |
| Normal-VS-KIRP CIMP |
4.230400E-04 |
| Normal-VS-Unclassified PRCC |
8.685200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.797500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.564200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.098000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.473900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.989900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.336400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.696000E-02 |
| Normal-vs-N1 |
3.908300E-02 |
| Normal-vs-N2 |
5.396400E-03 |
| N0-vs-N1 |
7.085400E-01 |
| N0-vs-N2 |
1.317580E-01 |
| N1-vs-N2 |
1.841800E-01 |
|
|
